HK1150756A1 - Antibiotic compositions for treatment of the ear - Google Patents

Antibiotic compositions for treatment of the ear

Info

Publication number
HK1150756A1
HK1150756A1 HK11104778.7A HK11104778A HK1150756A1 HK 1150756 A1 HK1150756 A1 HK 1150756A1 HK 11104778 A HK11104778 A HK 11104778A HK 1150756 A1 HK1150756 A1 HK 1150756A1
Authority
HK
Hong Kong
Prior art keywords
ear
treatment
antibiotic compositions
antibiotic
compositions
Prior art date
Application number
HK11104778.7A
Other languages
English (en)
Chinese (zh)
Inventor
Gerald Cagle
Robert L Abshire
David W Stroman
John M Yanni
Original Assignee
Alcon Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26799441&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1150756(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Pharmaceuticals Ltd filed Critical Alcon Pharmaceuticals Ltd
Publication of HK1150756A1 publication Critical patent/HK1150756A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK11104778.7A 1998-09-30 2002-01-02 Antibiotic compositions for treatment of the ear HK1150756A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10250498P 1998-09-30 1998-09-30
US10250698P 1998-09-30 1998-09-30

Publications (1)

Publication Number Publication Date
HK1150756A1 true HK1150756A1 (en) 2012-01-13

Family

ID=26799441

Family Applications (4)

Application Number Title Priority Date Filing Date
HK11104892.8A HK1150769A1 (en) 1998-09-30 2002-01-02 Antibiotic compositions for treatment of the eye
HK04102444.4A HK1059572A1 (en) 1998-09-30 2002-01-02 Antibiotic compositions containing moxifloxacin for treatment of the eye
HK11104778.7A HK1150756A1 (en) 1998-09-30 2002-01-02 Antibiotic compositions for treatment of the ear
HK02100003.3A HK1038691B (zh) 1998-09-30 2002-01-02 治療眼病症的抗生素合成劑

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HK11104892.8A HK1150769A1 (en) 1998-09-30 2002-01-02 Antibiotic compositions for treatment of the eye
HK04102444.4A HK1059572A1 (en) 1998-09-30 2002-01-02 Antibiotic compositions containing moxifloxacin for treatment of the eye

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK02100003.3A HK1038691B (zh) 1998-09-30 2002-01-02 治療眼病症的抗生素合成劑

Country Status (18)

Country Link
EP (5) EP2301541B1 (tr)
JP (5) JP2002525317A (tr)
KR (1) KR101463243B1 (tr)
CN (2) CN100374114C (tr)
AR (2) AR020661A1 (tr)
AT (2) ATE254458T1 (tr)
AU (1) AU762827B2 (tr)
BR (1) BRPI9914151B1 (tr)
CA (3) CA2659064A1 (tr)
CY (3) CY1111404T1 (tr)
DE (2) DE69943287D1 (tr)
DK (5) DK2269602T3 (tr)
ES (4) ES2526521T3 (tr)
HK (4) HK1150769A1 (tr)
PT (5) PT1384478E (tr)
TR (2) TR200704370T2 (tr)
TW (1) TWI222361B (tr)
WO (1) WO2000018386A2 (tr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
DE19937115A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
AU776609B2 (en) 1999-09-24 2004-09-16 Novartis Ag Topical suspension formulations containing ciprofloxacin and dexamethasone
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
WO2001089495A2 (en) * 2000-05-19 2001-11-29 Alcon Laboratories, Inc. Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose
CA2412575C (en) 2000-07-26 2009-12-29 Onkar N. Singh Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone
WO2002040028A1 (fr) * 2000-11-16 2002-05-23 Wakamoto Pharmaceutical Co., Ltd. Gouttes pour les yeux en gel antibacterien
AU2002226926A1 (en) * 2000-12-20 2002-07-01 Alcon, Inc. Antifungal compositions containing an antibiotic and one or more amidoamines
WO2002049633A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Use of amidoamines to treat or prevent acanthamoeba and fungal infections
EP1429780B1 (en) 2001-09-21 2005-12-21 Alcon, Inc. Method of treating middle ear infections
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
AU2005282571A1 (en) * 2004-09-03 2006-03-16 Piedmont Pharmaceuticals, Llc Methods for transmembrane treatment and prevention of otitis media
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
WO2006065301A2 (en) * 2004-12-10 2006-06-22 Alcon, Inc. Compositions for treatment of ear infections
CN101317847B (zh) * 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
TWI544934B (zh) * 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
AR077372A1 (es) * 2009-07-02 2011-08-24 Alcon Res Ltd Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
CA2786525A1 (en) * 2010-01-07 2011-07-14 Regents Of The University Of Minnesota Methods and compositions for applying moxifloxacin to the ear
RU2014127492A (ru) 2011-12-06 2016-02-10 Алькон Рисерч, Лтд. Композиции целлюлозного геля с улучшенной стабильностью вязкости
RU2472507C1 (ru) * 2012-02-01 2013-01-20 Закрытое акционерное общество "Брынцалов-А" Водный состав на основе моксифлоксацина для парентерального введения
US9504691B2 (en) * 2012-12-06 2016-11-29 Alcon Research, Ltd. Finafloxacin suspension compositions
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
CN104224802B (zh) * 2014-09-19 2017-12-12 南京优科生物医药研究有限公司 一种盐酸莫西沙星滴耳剂及其制备方法
RU2595837C2 (ru) * 2014-09-29 2016-08-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазных капель
EP3369422A4 (en) * 2015-10-29 2018-12-05 Teika Pharmaceutical Co., Ltd. External preparation
WO2019193513A1 (en) * 2018-04-03 2019-10-10 Hyderabad Eye Research Foundation Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics
IT201900005280A1 (it) * 2019-04-05 2020-10-05 Ntc S R L Composizione otologica
EP4164625A1 (en) * 2020-06-10 2023-04-19 Ocular Science, Inc. Compositions and uses in method for post-operative ocular care
KR102656260B1 (ko) 2022-10-14 2024-04-09 주식회사태준제약 목시플록사신을 포함하는 안과용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223493A (en) 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4910225A (en) * 1988-01-27 1990-03-20 Senju Pharmaceutical Co., Ltd. Locally administrable therapeutic composition for inflammatory disease
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
AU4201189A (en) * 1988-08-26 1990-03-23 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
JPH03109236A (ja) * 1989-09-22 1991-05-09 Hoya Corp 半導体超微粒子分散ガラスの製造方法
JPH085779B2 (ja) * 1989-09-22 1996-01-24 杏林製薬株式会社 フレロキサシン点眼液
TW209865B (tr) * 1992-01-10 1993-07-21 Bayer Ag
DE69333850T3 (de) 1992-05-06 2011-03-17 Alcon Laboratories, Inc., Fort Worth Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen
DE4424369A1 (de) * 1994-07-11 1996-01-18 Bayer Ag Pyrido[3,2,1.i,j][3,1]benzoxazinderivate
JPH0892241A (ja) * 1994-09-22 1996-04-09 Ss Pharmaceut Co Ltd ５−ヒドラジノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
IL120317A (en) * 1995-06-06 2000-08-13 Bayer Ag Ciprofloxacin-hydrocortisone suspension
JP3290914B2 (ja) * 1997-03-17 2002-06-10 参天製薬株式会社 眼組織におけるキノロン系抗菌剤の定量装置
CN1623533A (zh) * 1997-09-25 2005-06-08 拜尔公司 控释活性化合物的药物制剂
WO2000018366A1 (en) 1998-09-23 2000-04-06 Unilever N.V. Oral composition with an improved teeth whitening effect
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
KR20010107754A (ko) * 2000-05-26 2001-12-07 민경윤 경구투여용 속용정의 제조 방법

Also Published As

Publication number Publication date
AR020661A1 (es) 2002-05-22
TWI222361B (en) 2004-10-21
HK1150769A1 (en) 2012-01-13
AR081393A2 (es) 2012-08-29
DE69943287D1 (de) 2011-04-28
EP2301541B1 (en) 2014-08-20
EP1384478A1 (en) 2004-01-28
WO2000018386A2 (en) 2000-04-06
EP1384478B1 (en) 2011-03-16
JP2013018799A (ja) 2013-01-31
ES2526521T3 (es) 2015-01-13
PT1117401E (pt) 2004-03-31
CN1650863A (zh) 2005-08-10
CA2342211A1 (en) 2000-04-06
DK1117401T3 (da) 2004-02-23
HK1038691B (zh) 2004-04-23
EP2796138A1 (en) 2014-10-29
TR200704370T2 (tr) 2007-11-21
JP2002525317A (ja) 2002-08-13
JP5563041B2 (ja) 2014-07-30
JP2009007375A (ja) 2009-01-15
CA2659064A1 (en) 2000-04-06
HK1038691A1 (en) 2002-03-28
DK2301541T3 (da) 2014-09-01
CY1115759T1 (el) 2017-01-25
EP1117401A2 (en) 2001-07-25
CY1111404T1 (el) 2015-08-05
KR20010075138A (ko) 2001-08-09
CN100374114C (zh) 2008-03-12
JP2014144982A (ja) 2014-08-14
PT2301541E (pt) 2014-10-29
ATE501732T1 (de) 2011-04-15
CA2342211C (en) 2009-05-26
EP2301541A1 (en) 2011-03-30
BRPI9914151B1 (pt) 2017-10-03
PT2269602E (pt) 2014-12-29
DK2269602T3 (en) 2014-12-15
HK1059572A1 (en) 2004-07-09
DK1384478T3 (da) 2011-05-23
ES2519190T3 (es) 2014-11-06
EP2796138B1 (en) 2016-08-17
BR9914151A (pt) 2001-06-26
ES2207307T3 (es) 2004-05-16
JP2012067141A (ja) 2012-04-05
WO2000018386A3 (en) 2000-06-08
CA2774207A1 (en) 2000-04-06
AU1310100A (en) 2000-04-17
CN1320035A (zh) 2001-10-31
ES2602956T3 (es) 2017-02-23
DE69912972T2 (de) 2004-04-22
PT1384478E (pt) 2011-05-12
AU762827B2 (en) 2003-07-03
PT2796138T (pt) 2016-09-22
EP2269602A1 (en) 2011-01-05
EP2269602B1 (en) 2014-11-19
CN1184968C (zh) 2005-01-19
DK2796138T3 (en) 2016-12-05
ATE254458T1 (de) 2003-12-15
TR200100883T2 (tr) 2001-10-22
DE69912972D1 (de) 2003-12-24
CY1115916T1 (el) 2017-01-25
KR101463243B1 (ko) 2014-12-17
BRPI9914151B8 (tr) 2021-05-25
EP1117401B1 (en) 2003-11-19

Similar Documents

Publication Publication Date Title
HK1150756A1 (en) Antibiotic compositions for treatment of the ear
EP1066018B8 (en) Hair treatment compositions
HK1038693A1 (zh) 治療眼、耳、鼻病症的抗生素合成劑
PL330949A1 (en) Antibacterial compositions
PL345315A1 (en) Treatment of airborne microorganisms
AU6157700A (en) Malodour treatment compositions
PL330981A1 (en) Compositions of throwafloxacin mesilate
HK1038692A1 (zh) 治療眼、耳、鼻病症的抗生素合成劑
HK1038694A1 (zh) 治療眼、耳、鼻病症的抗生素合成劑
AU1772399A (en) Well treatment
AU1697197A (en) Immunoconjugate for the treatment of aids
AU2021601A (en) Composition for the treatment of dandruff
AUPQ197899A0 (en) Biomedical compositions
PL342733A1 (en) Biocement of improved properties
AU4144000A (en) Compositions for treating brain infarction
EP1096927A4 (en) STRESS TREATMENT COMPOSITION
AU2683500A (en) Compositions for the treatment of pain
AU2026400A (en) Treatment of myelogenous leukemia
AU4706799A (en) Treatment of (staphylococcus) infections
AU5524399A (en) Inorgasmia treatment
AUPQ267599A0 (en) Compositions for treating ear infections
IL124878A0 (en) Composition for the treatment of seborrhea
AUPP318898A0 (en) Therapeutic compositions
GB9917160D0 (en) Maldour treatment compositions
TW354479U (en) Improvement of earpick

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180927